Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
256.00
Ask:
265.00
Spread: 9.00 (3.516%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Trading Statement

23 Jul 2025 07:00

RNS Number : 1038S
Wilmington PLC
23 July 2025
 

23 July 2025

Wilmington plc

 

Year-end trading update

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2025.

 

Revenue growth from the Group's ongoing* businesses is expected to be 11%, led by both recent acquisitions in the HSE sector delivering double-digit percentage growth.

 

As at the half year, seven out of nine businesses grew year on year. Following the portfolio changes last year of two disposals and two acquisitions, and the continuing disruption in the US healthcare insurance market impacting our US events business over a full year, reported revenue is expected to be £101.5m (2024: £126m), with organic** revenue also having decreased 1% due to the US.

 

Operating profit from ongoing* businesses is expected to be up 11%, adjusted*** profit before tax is expected to be £27.7m (2024: £27.6m), with adjusted PBT margin up to 27% (2024: 22%).

 

Cash conversion continued to be strong at 107% of profits, with Group net cash on 30 June 2025 at £41.9m (30 June 2024: £67.8m) after the completion of the acquisition of Phoenix Health & Safety on 25 October 2024 and spending £3.4m on share buybacks.

 

Wilmington expects to publish its year end results on 22 September 2025.

 

Mark Milner, Chief Executive Officer, commented:

 

"We have seen another year of good ongoing* revenue and profit growth with both measures increasing 11%, reflecting our focus on a slimmed down higher quality portfolio of growing businesses. Margins have also continued to improve and both of our recent acquisitions have seen double digit growth. This performance came against a tough macro backdrop, particularly in the US healthcare market which has seen continued disruption in the course of our H2.

 

"With the acquisition of Phoenix, we have continued to actively manage our portfolio of businesses and are pursuing various opportunities to invest our cash in acquisitions to improve the quality of revenue and profits."

 

*Ongoing - eliminating the effects of the impact of disposals, closures and businesses held for sale.

**Organic - Ongoing, eliminating acquisitions and exchange rate fluctuations

***Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation and impairment of intangible assets (except computer software) and profits/losses on disposals and business closures. Market consensus adjusted profit before tax is £27.0m.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs around 600 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUUUORVWUBUAR
Date   Source Headline
27th Sep 20132:29 pmRNSShare Awards
19th Sep 20137:00 amRNSPreliminary Results
12th Sep 20132:24 pmRNSHolding(s) in Company
3rd Sep 201310:15 amRNSTotal Voting Rights
27th Aug 20133:57 pmRNSHolding(s) in Company
16th Aug 20137:00 amRNSAcquisition of Compliance Week
5th Aug 20133:22 pmRNSTotal Voting Rights
10th Jul 201311:04 amRNSHolding(s) in Company
1st Jul 20139:59 amRNSTotal Voting Rights
27th Jun 201312:41 pmRNSNotice of Results
4th Jun 20139:45 amRNSVoting Rights and Capital
16th May 20137:00 amRNSInterim Management Statement
10th May 20133:03 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st May 201310:16 amRNSTotal Voting Rights
3rd Apr 20134:18 pmRNSVoting Rights and Capital
26th Mar 201311:04 amRNSHolding(s) in Company
15th Mar 20134:40 pmRNSSecond Price Monitoring Extn
15th Mar 20134:37 pmRNSPrice Monitoring Extension
4th Mar 20137:00 amRNSAcquisition of Inese
1st Mar 201310:56 amRNSTotal Voting Rights
26th Feb 20137:00 amRNSInterim Results
7th Feb 20133:39 pmRNSAcquisition
6th Feb 201310:41 amRNSTotal Voting Rights
4th Jan 20133:00 pmRNSNotice of Results
2nd Jan 201311:31 amRNSVoting Rights and Capital
24th Dec 201211:12 amRNSProperty Sale
21st Dec 20127:00 amRNSSegmental Analysis
18th Dec 20124:40 pmRNSSecond Price Monitoring Extn
18th Dec 20124:35 pmRNSPrice Monitoring Extension
4th Dec 20129:08 amRNSTotal Voting Rights
22nd Nov 20124:45 pmRNSHolding(s) in Company
16th Nov 20123:05 pmRNSBlocklisting Interim Review
16th Nov 20123:00 pmRNSBoard Change
16th Nov 20127:00 amRNSCapital Markets Day
14th Nov 20124:00 pmRNSResult of AGM
14th Nov 20127:00 amRNSInterim Management Statement
13th Nov 20125:00 pmRNSHolding(s) in Company
2nd Nov 20121:28 pmRNSTotal Voting Rights
29th Oct 20122:19 pmRNSDirector/PDMR Shareholding
11th Oct 20124:20 pmRNSHolding(s) in Company
11th Oct 20122:32 pmRNSHolding(s) in Company
11th Oct 201210:06 amRNSDirector/PDMR Shareholding
10th Oct 20125:30 pmRNSTreasury Shares
2nd Oct 20122:45 pmRNSVoting Rights and Capital
18th Sep 20127:00 amRNSFinal Results
3rd Sep 20123:13 pmRNSVoting Rights and Capital
17th Aug 201212:10 pmRNSHolding(s) in Company
2nd Aug 201210:31 amRNSTotal Voting Rights
24th Jul 20124:37 pmRNSHolding(s) in Company
13th Jul 20124:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.